Suppr超能文献

甘露醇减轻缺血性损伤的机制:高渗作用还是羟基清除剂作用?

The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger?

作者信息

Magovern G J, Bolling S F, Casale A S, Bulkley B H, Gardner T J

出版信息

Circulation. 1984 Sep;70(3 Pt 2):I91-5.

PMID:6086178
Abstract

The effectiveness of postischemic reperfusion with mannitol has been well documented in previous studies. Mannitol, a hyperosmolar agent, is also an effective scavenger of the cytotoxic hydroxyl radical. If mannitol acts solely as a hyperosmolar agent, hyperosmolar reperfusion with its isomer, glucose, should be equally effective. To elucidate the beneficial effect of mannitol, 24 isolated rabbit heart preparations were subjected to 60 min of hypothermic (27 degrees C) cardioplegic arrest and normothermic reperfusion. There were three study groups with eight hearts in each. Group I hearts were reperfused with an unmodified isosmolar solution. Group II hearts were reperfused with a hyperosmolar (350 mOsm/liter) solution containing glucose, and group III hearts had hyperosmolar (350 mOsm/liter) reperfusion with mannitol. Left ventricular function (developed pressure and maximum positive dP/dt) was measured isovolumically before and after ischemia. Coronary flow was measured volumetrically during reperfusion, and myocardial edema formation was determined after 45 min of reperfusion. Reperfusion with mannitol resulted in significant improvement in recovery of developed pressure (77.3 +/- 2.8% of control vs 65.5 +/- 2.9% in group I and 62.6 +/- 2.2% in group II; p less than .05). Mannitol-treated hearts also had significantly greater coronary flow throughout the reperfusion period and significantly less marked myocardial edema formation compared with hearts treated with isosmolar and hyperosmolar glucose. These data confirm the particular usefulness of mannitol in improving postischemic ventricular function, maintaining coronary blood flow during early reflow, and reducing myocardial edema formation.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在先前的研究中,甘露醇用于缺血后再灌注的有效性已有充分记录。甘露醇是一种高渗剂,也是细胞毒性羟基自由基的有效清除剂。如果甘露醇仅作为高渗剂起作用,那么用其异构体葡萄糖进行高渗再灌注应该同样有效。为了阐明甘露醇的有益作用,对24个离体兔心标本进行了60分钟的低温(27摄氏度)心脏停搏和常温再灌注。分为三个研究组,每组8个心脏。第一组心脏用未改良的等渗溶液进行再灌注。第二组心脏用含有葡萄糖的高渗(350毫渗量/升)溶液进行再灌注,第三组心脏用甘露醇进行高渗(350毫渗量/升)再灌注。在缺血前后等容测量左心室功能(舒张末压和最大正dP/dt)。在再灌注期间测量冠状动脉血流量,并在再灌注45分钟后测定心肌水肿形成情况。用甘露醇进行再灌注使舒张末压恢复情况有显著改善(对照组为77.3±2.8%,第一组为65.5±2.9%,第二组为62.6±2.2%;p<0.05)。与用等渗和高渗葡萄糖处理的心脏相比,用甘露醇处理的心脏在整个再灌注期间冠状动脉血流量也显著增加,心肌水肿形成也明显减轻。这些数据证实了甘露醇在改善缺血后心室功能、在早期再灌注期间维持冠状动脉血流以及减少心肌水肿形成方面的特殊效用。(摘要截短为250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验